Stryker Corporation $SYK Position Lifted by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its position in shares of Stryker Corporation (NYSE:SYK) by 0.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,157,166 shares of the medical technology company’s stock after acquiring an additional 2,209 shares during the quarter. Stryker makes up approximately 3.0% of Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s portfolio, making the stock its 8th biggest position. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Stryker were worth $318,672,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of SYK. Gables Capital Management Inc. acquired a new position in Stryker in the 2nd quarter worth about $25,000. Kilter Group LLC acquired a new stake in shares of Stryker during the second quarter valued at about $25,000. Highland Investment Advisors LLC bought a new stake in shares of Stryker during the second quarter worth about $25,000. Cornerstone Financial Management LLC grew its holdings in shares of Stryker by 66.0% during the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock worth $25,000 after purchasing an additional 31 shares during the last quarter. Finally, Compass Financial Management LLC bought a new stake in shares of Stryker during the second quarter worth about $27,000. Institutional investors own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on SYK. Wall Street Zen downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, October 3rd. Royal Bank Of Canada decreased their price target on shares of Stryker from $435.00 to $420.00 and set an “outperform” rating for the company in a research report on Friday, July 31st. Truist Financial decreased their price target on shares of Stryker from $340.00 to $310.00 and set a “hold” rating for the company in a research report on Tuesday, October 6th. BMO Capital Markets reaffirmed an “outperform” rating and set a $317.00 price target on shares of Stryker in a research note on Wednesday, September 9th. Finally, Piper Sandler cut their price target on shares of Stryker from $420.00 to $390.00 and set an “overweight” rating on the stock in a report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $369.00.

Stryker Price Performance

Shares of SYK opened at $307.65 on Monday. Stryker Corporation has a 1 year low of $267.00 and a 1 year high of $389.33. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The company has a market capitalization of $118.01 billion, a price-to-earnings ratio of 31.88, a price-to-earnings-growth ratio of 1.98 and a beta of 0.78. The business has a 50-day moving average of $295.23 and a 200-day moving average of $311.79.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The company had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. During the same period in the previous year, the firm earned $3.13 earnings per share. The firm’s quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities research analysts anticipate that Stryker Corporation will post 14.93 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is presently 36.48%.

Insider Transactions at Stryker

In other news, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the sale, the insider directly owned 6,210 shares in the company, valued at $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Ronda E. Stryker sold 300,000 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the sale, the director owned 2,301,375 shares of the company’s stock, valued at approximately $773,031,862.50. This trade represents a 11.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 351,267 shares of company stock worth $118,197,701. Company insiders own 4.60% of the company’s stock.

Stryker Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.